Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastroesophageal Reflux 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Biopsy 6Endoscopy, Digestive System 4Endoscopy 4Esomeprazole 3Specimen Handling 2Proton Pump Inhibitors 2Lansoprazole 2Blood Specimen Collection 2plecanatide 1omeprazole, sodium bicarbonate drug combination 1linaclotide 1ilaprazole 1YF 476 1Urine Specimen Collection 1Tumor Burden 1Surveys and Questionnaires 1Rabeprazole 1Quality of Life 1Lysine Acetyltransferase 5 1Gastropexy 1Gastroenterostomy 1Gastric Bypass 1Fundoplication 1Endoscopic Mucosal Resection 1Endoscopes 1Diet, Gluten-Free 1Dexlansoprazole 1Decision Support Techniques 1Cryoelectron Microscopy 1Anastomosis, Roux-en-Y 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastroesophageal Reflux × YF 476 × Clear all
NCT01298999 2021-11-23

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Columbia University

Phase 2 Completed
27 enrolled 16 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡